Press Releases

07.07.2011

Pfizer To Explore Strategic Alternatives For Its Animal Health And Nutrition Businesses

07.05.2011

A prototype Handheld Device that Analyses DNA to Predict How Patients May Respond to their Prescription Medication has Performed Well in a Preliminary Pilot Study, Researchers Announce Today.

07.05.2011

Cell Signaling Technology, Inc. Grants a Patent License to Pfizer

06.14.2011

pSivida Announces Phase I/II Clinical Study Evaluating Bioerodible, Sustained Release Latanoprost Device in Ocular Hypertension and Glaucoma

06.09.2011

Lpath Granted 22nd Patent Related to Lipidomics-Based Drug Development Program

06.02.2011

Pfizer and Hisun Sign MOU to Increase Access to Quality and Low-Cost Medicines for Patients in China

06.02.2011

Clovis Oncology, Inc. Receives License for Worldwide Development and Commercialization Rights to Pfizer’s Oral and IV PARP Inhibitor PF-01367338

05.10.2011

Foundation for the NIH Launches Trial to Develop Diabetes Diagnostic Tools

05.10.2011

Cellzome to Study Epigenetic Factors with Neusentis

05.09.2011

Staphylococcus aureus Investigational Vaccine Elicits a Positive Immune Response in Phase 1 Study

05.04.2011

Oxford BioMedica Broadens 5T4 Antibody Collaboration With Pfizer

04.07.2011

Zacharon Pharmaceuticals Announces Research and Development Collaboration with Pfizer to Develop Drugs for Multiple Rare Disorders